Doctors Note Logo

Published on: 5/22/2026

Why Dupixent Can Bring Back the Sense of Smell: The True Remission Science

By blocking IL 4 and IL 13 signaling, Dupixent reduces type 2 inflammation to shrink nasal polyps and restore olfactory nerve function, enabling rapid smell recovery in most CRSwNP patients with sustained benefits through one year.

Important details on who may benefit, administration schedule, cost, insurance requirements, safety monitoring and realistic timelines for improvement are outlined below. See below for a complete picture before deciding on your next steps.

answer background

Explanation

Why Dupixent Can Bring Back the Sense of Smell: The True Remission Science

Loss of smell (anosmia) is one of the most distressing symptoms of chronic rhinosinusitis with nasal polyps (CRSwNP). For many patients, no amount of nasal sprays, steroids or even surgery fully restores their ability to smell. That's where Dupixent® (dupilumab) comes in. But can Dupixent bring back sense of smell nasal polyps really? Let's explore the science behind true remission, what the clinical trials show, and what you should consider before starting therapy.


Understanding the Link: Nasal Polyps, Inflammation, and Smell

  • Chronic rhinosinusitis with nasal polyps (CRSwNP)
    A long-term inflammatory condition of the nasal passages and sinuses. Polyps are non-cancerous growths that block airways and mucus drainage.
  • Inflammatory drivers: IL-4 and IL-13
    These immune system proteins (cytokines) are over-produced in CRSwNP, causing tissue swelling, polyp growth, mucus overproduction and nerve dysfunction in the olfactory cleft (smell-detecting area).
  • Why smell is lost
    Blocked airflow prevents odor molecules from reaching olfactory receptors. Chronic inflammation also damages the delicate nerve endings that transmit smell signals to the brain.

How Dupixent Targets the Root Cause

Dupixent is a monoclonal antibody that specifically blocks IL-4 and IL-13 signaling. By doing so, it:

  • Reduces type 2 inflammation driving polyp growth
  • Decreases mucus production and tissue swelling
  • Improves sinus ventilation and drainage
  • Protects and restores the olfactory mucosa and nerve function

Rather than temporarily shrinking polyps like steroids, Dupixent disrupts the underlying immune cascade, offering the potential for sustained, true remission.


Key Clinical Trial Findings

Two pivotal studies—SINUS-24 and SINUS-52—evaluated Dupixent in adults with CRSwNP already on standard therapy.

Patient Population

  • History of at least one sinus surgery
  • Moderate-to-severe polyps despite intranasal steroids
  • Baseline loss of smell common in >60%

Primary Outcomes

  • Reduction in nasal polyp size (endoscopic grading)
  • Improvement in nasal congestion score

Sense of Smell: A Standout Benefit

  • Rapid improvement in smell by Week 4
  • Mean smell score increase of 3–4 points (10-point scale) at Week 24
  • 70% of patients reported clinically meaningful smell recovery by Week 52

  • Benefits maintained through one year of treatment in SINUS-52

These data show that blocking IL-4/IL-13 not only shrinks polyps but allows repair of the olfactory system.


True Remission vs. Temporary Relief

Many treatments offer short-lived symptom control:

  • Intranasal and oral steroids
    Can shrink polyps but carry side effects (bone thinning, adrenal suppression) if used long term.
  • Surgical polypectomy
    Opens airflow but doesn't stop inflammation—polyps often recur within months.

Dupixent's approach:

  • Intervenes upstream in the inflammatory pathway
  • Lowers the risk of polyp regrowth
  • Provides sustained symptom relief, including sense of smell
  • Reduces the need for repeat surgery or systemic steroids

Who Might Benefit?

Consider a Dupixent consultation if you have:

  • CRSwNP with moderate-to-severe polyps
  • Persistent nasal obstruction, congestion or runny nose despite standard therapy
  • Significant loss of smell affecting quality of life
  • History of repeated sinus surgeries or oral steroid courses

If you're experiencing nasal polyp symptoms or loss of smell and want to understand your condition better before your doctor visit, use this free Medically approved LLM Symptom Checker Chat Bot to explore your symptoms and get personalized health insights.


Safety Profile and Monitoring

Dupixent is generally well tolerated, but it's important to discuss potential side effects and monitoring with your doctor:

Common (≥2% of patients)

  • Injection-site reactions (redness, swelling)
  • Conjunctivitis or eye irritation
  • Eosinophilia (high eosinophil counts); usually mild and transient

Less common

  • Allergic reactions
  • Joint pain

Monitoring may include periodic blood tests and eye exams. Always report new or worsening symptoms to your healthcare provider.


Practical Considerations

Before starting Dupixent:

  • Insurance coverage & cost
    Dupixent is expensive; most insurance plans require prior authorization. Ask about patient assistance programs.
  • Administration
    Self-administered subcutaneous injections every 2 weeks. Training and support are provided.
  • Timeframe for benefit
    Some patients feel smell improvement within 2–4 weeks; full benefits often require 3–6 months of continuous therapy.
  • Long-term plan
    Dupixent is a chronic treatment. Discuss with your doctor how long you might stay on therapy and strategies for eventual tapering or discontinuation if remission is achieved.

Patient Stories: Real-World Remissions

While individual experiences vary, here are some common themes from patients who have regained their sense of smell:

  • "I could finally smell my morning coffee again after 6 weeks."
  • "My polyps are almost gone, and I haven't needed oral steroids in over a year."
  • "I noticed flower and food aromas return little by little—best feeling ever."

These anecdotes mirror the clinical trial data, reinforcing the potential for life-changing benefits.


Next Steps: Talk With Your Doctor

Dupixent represents a breakthrough in targeting the underlying causes of CRSwNP and anosmia. If you're struggling with nasal polyps and loss of smell:

  1. Discuss Dupixent with your ENT specialist or allergist.
  2. Review your medical history, current therapies and any contraindications.
  3. Before your appointment, try this Medically approved LLM Symptom Checker Chat Bot to document your symptoms and prepare informed questions for your healthcare provider.

Always speak to a healthcare professional about any treatment changes. If you experience severe symptoms—such as sudden, complete loss of smell, high fever, severe facial pain, or vision changes—seek medical attention promptly, as these may signal complications requiring urgent care.


Dupixent offers hope for genuine, lasting remission of nasal polyp symptoms and a return of the sense of smell. While not a cure, its targeted mechanism addresses the immune dysfunction at the heart of the disease. Speak to your doctor today to see if Dupixent could help you breathe easier, smell better, and reclaim your quality of life.

(References)

  • * Geng C, Zhang W, Cui H, et al. Effect of Dupilumab on Olfactory Function in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2022 Jul;167(1):50-58.

  • * Tan BK, Evans T, Peters AT, et al. Sustained Improvement in Olfaction After Dupilumab Treatment for Chronic Rhinosinusitis With Nasal Polyps. Am J Rhinol Allergy. 2021 Jan;35(1):103-110.

  • * Bachert C, Han JK, Lange B, et al. Improvement of Olfactory Function in Patients With Chronic Rhinosinusitis With Nasal Polyps Treated With Dupilumab. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1218-1226.e2.

  • * Stevens WW, Tan BK, Tan JS, et al. Dupilumab Improves Objective Olfactory Function in Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2775-2777.e1.

  • * Bachert C, Hellings PW, Mullol J, et al. Long-term efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps: an open-label extension study. Lancet Respir Med. 2020 Sep;8(9):890-900.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.